Dietary intake of lignans and risk of adenocarcinoma of the esophagus and gastroesophageal junction

Cancer Causes and Control

Volumn 23, Issue 6, 2012, Pages 837-844

  Lin, Yulan ^a   Yngve, Agneta ^b,c   Lagergren, Jesper ^a,d   Lu, Yunxia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diet; Esophagus; Lignans; Neoplasm; Phytoestrogen

Indexed keywords

LIGNAN DERIVATIVE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK REDUCTION; SWEDEN;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DIET; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LIGNANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHYTOESTROGENS; RISK FACTORS; STOMACH NEOPLASMS; SWEDEN;

EID: 84862506017     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9952-7     Document Type: Article

References (43)

1. Cook MB, Chow WH, Devesa SS (2009) Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 101:855-859
2. Lindblad M, Garcia Rodriguez LA, Chandanos E, Lagergren J (2006) Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 94:136-141 (Pubitemid 43088553)
3. Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ et al (2010) Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer 46:2067-2076
4. Lagergren J, Jansson C (2005) Sex hormones and oesophageal adenocarcinoma: influence of childbearing? Br J Cancer 93:859-861 (Pubitemid 41487009)
5. Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80:14-25 (Pubitemid 38967392)
6. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, Van der Saag P et al (2007) Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148(10):4875-4886 (Pubitemid 47481543)
7. Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU (1999) Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 202:91-100 (Pubitemid 30099742)
8. Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9:220-225
9. Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, Tsubura A (2005) Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res 25:2269-2276 (Pubitemid 40904633)
10. Adlercreutz H (2007) Lignans and human health. Crit Rev Clin Lab Sci 44:483-525
11. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T et al (2001) In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49:3178-3186 (Pubitemid 32845044)
12. McCann SE, Ambrosone CB, Moysich KB, Brasurela J, Marshall JR, Freudenheim JL et al (2005) Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53:33-41 (Pubitemid 43068551)
13. Sonestedt E, Ivarsson MI, Harlid S, Ericson U, Gullberg B, Carlson J et al (2009) The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes. J Nutr 139(5):993-1001
14. Johnsen NF, Olsen A, Thomsen BL, Christensen J, Egeberg R, Bach Knudsen KE et al (2010) Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women. Cancer Causes Control 21:153-162
15. Tiffin N, Suvarna SK, Trudgill NJ, Riley SA (2003) Sex hormone receptor immunohistochemistry staining in Barrett's oesophagus and adenocarcinoma. Histopathology 42:95-96 (Pubitemid 36062576)
16. Moore JT, McKee DD, Slentz-Kesler K et al (1998) Cloning and characterization of human estrogen receptor beta isoforms. Biochem Bioph Res Co 247:75-78 (Pubitemid 28412528)
17. Joubert A, Marais S (2007) In vitro effects of 2-methoxyestradiol on cell morphology and Cdc2 kinase activity in SNO oesophageal carcinoma cells. Cell Biochem Funct 25:357-362 (Pubitemid 46827131)
18. Yanagihara K, Ito A, Toge T, Numoto M (1993) Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 53:5815-5821
19. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11:7033-7041
20. Fukumitsu S, Aida K, Ueno N, Ozawa S, Takahashi Y, Kobori M (2008) Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr 100:669-676
21. Ogunwobi O, Mutungi G, Beales IL (2006) Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147:4505-4516 (Pubitemid 44268402)
22. Ogunwobi OO, Beales IL (2008) Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 285:43-50
23. Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV (2010) Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Brit J Surg 97:1020-1027
24. Gallus S, Bosetti C, Franceschi S, Levi F, Simonato L, Negri E et al (2001) Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br J Cancer 85:341-345 (Pubitemid 32747699)
25. Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831 (Pubitemid 29142625)
26. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883
27. Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000) The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340-346 (Pubitemid 30030406)
28. Jansson C, Johansson AL, Nyren O, Lagergren J (2005) Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev 14:1754-1761 (Pubitemid 40995091)
29. Ye WM, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK et al (2004) Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer I 96:388-396 (Pubitemid 38351300)
30. Wolk A, Bergstrom R, Hansson LE, Nyren O (1997) Reliability of retrospective information on diet 20 years ago and consistency of independent measurements of remote adolescent diet. Nutr Cancer 29:234-241 (Pubitemid 28063277)
31. Adlercreutz H, Mazur W (1997) Phyto-oestrogens and Western diseases. Ann Med 29:95-120 (Pubitemid 27226319)
32. Valsta LM, Kilkkinen A, Mazur W, Nurmi T, Lampi AM, Ovaskainen ML et al (2003) Phyto-oestrogen database of foods and average intake in Finland. Br J Nutr 89:S31-S38 (Pubitemid 36798243)
33. Mazur W (1998) Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab 12:729-742
34. Mazur WM, Duke JA, Wahala K, Rasku S, Adlercreutz H (1998) Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J Nutr Biochem 9:193-200 (Pubitemid 28202343)
35. Mazur WM, Wahala K, Rasku S, Salakka A, Hase T, Adlercreutz H (1998) Lignan and isoflavonoid concentrations in tea and coffee. Brit J Nutr 79:37-45 (Pubitemid 28058593)
36. Mazur W, Fotsis T, Wahala K, Ojala S, Salakka A, Adlercreutz H (1996) Isotope dilution gas chromatographic mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 233:169-180
37. Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC (2005) Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93:393-402
38. Mazur W, Adlercreutz H (2000) Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 16:654-658 (Pubitemid 30445140)
39. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N (2006) Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cance 54:184-201 (Pubitemid 44316301)
40. Swedish National Food Administration (2002) Available: http://www.slv.se/engdefault.asp
41. Becher W, Peason M (2002) Riksmaten 1997-1998. Metod och resultatanalys. Livesmedelsverket, Upplasa, Sweden
42. Willet W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York
43. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Harada T, Morikawa S (1991) Effect of 17-beta-estradiol on the growth of an estrogen receptor-positive human esophageal-carcinoma cellline. Cancer 67:2284-2289